New Synthetic Opioids: Clinical Considerations and Dangers
Abstract Since the early 2010s, synthetic opioids have significantly contributed to overall opioid-related overdose mortalities. For point of reference, of the 68,630 opioid-related deaths recorded in 2020, 56,516 involved synthetic opioids. During much of this period, fentanyl has been the most com...
Main Authors: | Amber N. Edinoff, David Martinez Garza, Stephen P. Vining, Megan E. Vasterling, Eric D. Jackson, Kevin S. Murnane, Adam M. Kaye, Richard N. Fair, Yair Jose Lopez Torres, Ahmed E. Badr, Elyse M. Cornett, Alan D. Kaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-02-01
|
Series: | Pain and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40122-023-00481-6 |
Similar Items
-
Psychostimulant drug co-ingestion in non-fatal opioid overdose
by: Siri Shastry, et al.
Published: (2024-03-01) -
Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose
by: Amber N. Edinoff, et al.
Published: (2021-10-01) -
Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case series
by: Taylor A. Ochalek, et al.
Published: (2023-06-01) -
Intentional use of both opioids and cocaine in the United States
by: Xiguang Liu, et al.
Published: (2023-06-01) -
Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review
by: Amber N. Edinoff, et al.
Published: (2023-07-01)